Skip to main content
SpringerLink
Log in

Erectile Dysfunction

  • Chapter
  • First Online:
Urology at a Glance

  • 2115 Accesses

Abstract

Erectile dysfunction (ED) is defined as the persistent inability to attain and maintain an erection sufficient to permit satisfactory sexual performance [1]. Referring to bigger epidemiological studies, the incidence of ED which requires medical treatment is reported to be 20 % in the mean. It is age-related and increases up to 70 % in 70-year-old patients. But also younger patients suffer from ED: 5 % of 40-year-old patients have a complete and 17 % a moderate ED [2, 3]. Risk factors are lack of exercise, obesity, smoking, hypercholesterolemia, and metabolic syndrome [4]. Psychological, vascular, neurogenic, endocrine, or myogenic disorders as well as drugs can be the cause of ED. Patients with ED have to be screened for diabetes, hypertension, and dyslipidemia since ED can be an early manifestation of cardiovascular disease [5, 6].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lue TF, Giuliano F, Montorsi F, et al. Summary of the recommendations on sexual dysfunctions in men. J Sex Med. 2004;1:6–23.

    Article  PubMed  Google Scholar 

  2. Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151(1):54–61.

    PubMed  CAS  Google Scholar 

  3. Braun M, Wassmer G, Klotz T, et al. Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey’. Int J Impot Res. 2000;12(6):305–11.

    Article  PubMed  CAS  Google Scholar 

  4. Gupta BP, Murad MH, Clifton MM, et al. The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med. 2011;171(20):1797–803.

    Article  PubMed  Google Scholar 

  5. Kostis JB, Jackson G, Rosen R, et al. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol. 2005;96:313–21.

    Article  PubMed  Google Scholar 

  6. Guo W, Liao C, Zou Y, Li F, Li T, Zhou Q, Cao Y, Mao X. Erectile dysfunction and risk of clinical cardiovascular events: a meta-analysis of seven cohort studies. J Sex Med. 2010;7(8):2805–16.

    Article  PubMed  Google Scholar 

  7. Sanda MG, Dunn RL, Michalski J, et al. Quality of life and satisfaction with outcome among prostate cancer survivors. N Engl J Med. 2008;358(12):1250–61.

    Article  PubMed  CAS  Google Scholar 

  8. van der Wielen GJ, Mulhall JP, Incrocci L. Erectile dysfunction after radiotherapy for prostate cancer and radiation dose to the penile structures: a critical review. Radiother Oncol. 2007;84(2):107–13.

    Article  PubMed  Google Scholar 

  9. Stember DS, Mulhall JP. The concept of erectile function preservation (penile rehabilitation) in the patient after brachytherapy for prostate cancer. Brachytherapy. 2012;11(2):87–96.

    Article  PubMed  Google Scholar 

  10. Greenstein A, Mabjeesh NJ, Sofer M, et al. Does sildenafil combined with testosterone gel improve erectile dysfunction in hypogonadal men in whom testosterone supplement therapy alone failed? J Urol. 2005;173(2):530–2.

    Article  PubMed  CAS  Google Scholar 

  11. Morales A, Heaton JP. Hormonal erectile dysfunction. Evaluation and management. Urol Clin North Am. 2001;28(2):279–88.

    Article  PubMed  CAS  Google Scholar 

  12. Lue TF. Erectile dysfunction. N Engl J Med. 2000;342(24):1802–13.

    Article  PubMed  CAS  Google Scholar 

  13. Leungwattanakij S, Flynn Jr V, Hellstrom WJ. Intracavernosal injection and intraurethral therapy for erectile dysfunction. Urol Clin North Am. 2001;28(2):343–54.

    Article  PubMed  CAS  Google Scholar 

  14. Coombs PG, Heck M, Guhring P, Narus J, Mulhall JP. A review of outcomes of an intracavernosal injection therapy programme. BJU Int. 2012;110(11):1787–91.

    Article  PubMed  CAS  Google Scholar 

  15. Padma-Nathan H, Hellstrom WJ, Kaiser FE, et al. Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group. N Engl J Med. 1997;336(1):1–7.

    Article  PubMed  CAS  Google Scholar 

  16. Shabsigh R, Padma-Nathan H, Gittleman M, et al. Intracavernous alprostadil alfadex is more efficacious, better tolerated, and preferred over intraurethral alprostadil plus optional actis: a comparative, randomized, crossover, multicentre study. Urology. 2000;55(4):109–13.

    Article  PubMed  CAS  Google Scholar 

  17. Levine LA, Dimitriou RJ. Vacuum constriction and external erection devices in erectile dysfunction. Urol Clin North Am. 2001;28(2):335–41, ix–x.

    Article  PubMed  CAS  Google Scholar 

  18. Martinez-Salamanca JI, Mueller A, Moncada I, et al. Penile prosthesis surgery in patients with corporal fibrosis: a state of the art review. J Sex Med. 2011;8(7):1880–9.

    Article  PubMed  Google Scholar 

  19. Bernal RM, Henry GD. Contemporary patient satisfaction rates for three-piece inflatable penile prostheses. Adv Urol. 2012;2012:707321.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Lakin MM, Montague DK, Vander Brug Medendorp S, et al. Intracavernous injection therapy: analysis of results and complications. J Urol. 1990;143(6):1138–41.

    PubMed  CAS  Google Scholar 

  21. Lewis RW, Witherington R. External vacuum therapy for erectile dysfunction: use and results. World J Urol. 1997;15(1):78–82.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology and Urological Oncology, Hannover University Medical School, Carl-Neuberg-Str. 1, Hannover, 30625, Germany

    Rebecca Bongers & George Kedia

Authors
  1. Rebecca Bongers
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. George Kedia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rebecca Bongers .

Editor information

Editors and Affiliations

  1. Dept. of Urology and Urologic Oncology, Medical School of Hanover (MHH), Hannover, Germany

    Axel S. Merseburger

  2. Department of Urology and Urologic Oncol, Medical School of Hanover (MHH), Hannover, Germany

    Markus A. Kuczyk

  3. Division of Urologic Surgery, Duke University Medical Center, Durham, North Carolina, USA

    Judd W. Moul

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Bongers, R., Kedia, G. (2014). Erectile Dysfunction. In: Merseburger, A., Kuczyk, M., Moul, J. (eds) Urology at a Glance. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54859-8_49

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-54859-8_49

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-54858-1

  • Online ISBN: 978-3-642-54859-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation